Connecta Therapeutics receives funding to expand therapeutic indications for its FXS drug CTH120
Connecta Therapeutics, a biotechnology company that specialises in the discovery and development of new treatments for unmet central nervous system (CNS) needs, has been granted €247,577 in funding through the Neotec programme, managed by the Spanish Ministry of Science and Innovation Centre for the Development...
Continue reading